Recent Quotes
My Watchlist
Indicators
Star 60
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exact Sciences Cor (NQ: EXAS )

67.77 -0.96 (-1.40%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,688,292
Open 68.68
Bid (Size) 66.00 (3)
Ask (Size) 67.50 (1)
Prev. Close 68.73
Today's Range 66.79 - 68.68
52wk Range 40.62 - 79.62
Shares Outstanding 171,948,769
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Exact Sciences Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024
From Exact Sciences Corp.
Via Business Wire

Performance

YTD
-8.13%
-8.13%
1 Month
+13.25%
+13.25%
3 Month
+53.46%
+53.46%
6 Month
+1.33%
+1.33%
1 Year
+2.02%
+2.02%

More News

Read More
Chewy, Broadcom And MicroStrategy Are Among Top 10 Large Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For Exact Sciences
Via Benzinga
Exact Sciences Analysts Slash Their Forecasts After Q2 Results
Via Benzinga
Peeling Back The Layers: Exploring Exact Sciences Through Analyst Insights
Via Benzinga
Exact Sciences To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Exact Sciences to Participate in September Investor Conferences
From Exact Sciences Corp.
Via Business Wire
Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG)
Via AB Newswire
Exposures COVID-19
Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG)
Via News Direct
Exposures COVID-19
Exact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study
From Exact Sciences Corp.
Via Business Wire
New Modeling Data Show the Cologuard® Test Has Detected More Than 623,000 Cancers and Precancers Over Past Decade, Saving U.S. Health Care System $22 Billion
From Exact Sciences Corp.
Via Business Wire
9 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
Via Benzinga
Crude Oil Moves Lower; Moderna Shares Plunge
Via Benzinga
Exposures Fossil Fuels
Dow Dips Over 500 Points; ISM Manufacturing PMI Falls In July
Via Benzinga
Topics Stocks
Exposures US Equities
Air Products Posts Upbeat Earnings, Joins Meta, Exact Sciences, Shake Shack, Clearwater Analytics And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Why Exact Sciences, Up 20%, Is 'Coiled To Snap Back' After Quarterly Beat
Via Investor's Business Daily
Exact Sciences (EXAS) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Exact Sciences Stock Climbs After Strong Q2 Results
Via Benzinga
Exact Sciences Announces Second-Quarter 2024 Results
From Exact Sciences Corp.
Via Business Wire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
FDA Greenlights Guardant Health's Shield Blood Test, Analyst Cautious on Adoption
Via Benzinga
Exposures Product Safety
Goldman Sachs Says Buy These 3 Stocks for Double-Digit Returns
Via InvestorPlace
This Cathie Wood Growth Stock Could Soar by 93%, According to Wall Street
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.